Skip to main content

UPDATE 1-Alexion Pharmaceuticals rejects Elliott push for "proactive sale"

Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously decided against hedge fund Elliott Management's push for a "proactive sale" process, saying it would not be in the best interest of shareholders.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.